Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 1-4 , 15 May 2010

Neuromuscular disorders associated with Hepatitis B vaccination

Received 21 January 2010 ,Revised 10 February 2010 ,Accepted 16 February 2010.

References 

  1. Centers for disease control and prevention . Protection against viral hepatitis. Recommendations of the immunization practices advisory committee (ACIP). MMWR. 1990;39:1–26
  2. Centers for disease control and prevention . Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the immunization practices advisory committee (ACIP). MMWR. 1991;40:1–19
  3. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263:1218–1222
  4. Francis DP, Favero MS, Maynard JE. Transmission of hepatitis B virus. Semin Liver Dis. 1981;1:27–32
  5. Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin Drug Saf. 2003;2:113–122
  6. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005;38:295–301
  7. Tishler M, Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J. 2004;6:430–432
  8. Altman A, Szyper-Kravitz M, Shoenfeld Y. HBV vaccine and dermatomyositis: is there an association?. Rheumatol Int. 2008;28:609–612
  9. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol. 2008;34:85–102
  10. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol. 2001;14:227–250
  11. Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol. 2000;18:181–184
  12. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun. 1996;9:699–703
  13. Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil. 2003;6:97–102
  14. Schijns VE. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol. 2000;12:456–463
  15. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18:1217–1225
  16. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5:648–652
  17. Duclos P. Safety of immunization and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf. 2003;2:225–231
  18. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine. 2005;23:3876–3886
  19. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity — ‘vaccinosis’: a dangerous liaison?. J Autoimmun. 2000;14:1–10
  20. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl. 2001;235:3–15
  21. Miller FW, Hess EV, Clauw DJ, Hertzman PA, Pincus T, Silver RM, et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum. 2000;43:243–249
  22. Créange A, Temem G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity. 1999;30:143–146
  23. Seti NK, Reddi R, Anand I, Sethi PK. Guillain-Barré syndrome following vaccination with hepatitis B vaccine. J Assoc Physicians India. 2002;50:989
  24. Sinsawaiwong S, Thampanitchawong P. Guillain-Barré following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai. 2000;83:1124–1126
  25. Kakar A, Sethi PK. Guillain-Barré syndrome associated with hepatitis B vaccination. Indian J Pediatr. 1997;64:710–712
  26. Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barré syndrome following hepatitis B vaccination. Clin Exp Rheumatol. 2004;22:767–770
  27. Sindern E, Schroder JM, Krismann M, Malin JP. Inflammatory polyradiculoneuropathy and spinal cord involvement and lethal outcome after hepatitis B vaccine. J Neurol Sci. 2001;186:81–85
  28. Tuohy PG. Guillain-Barré syndrome following immunization with synthetic hepatitis B vaccine. NZ Med J. 1989;102:114–115
  29. MacMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43, 618 persons. Am J Med. 1992;92:254–257
  30. Maillefert JF, Farge P, Gazet-Maillefert MP, Tavernier C. Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:663–664
  31. De Jonckere PH, de Surgéres GG. Acute tinnitus and permanent audiovestibular damage after hepatitis B vaccination. Int Tinnitus J. 2001;7:59–61
  32. Dano M, Korczyn AD. Precipitation of hereditary motor-sensory neuropathy following hepatitis B vaccination. J Clin Neuromuscul Dis. 2001;3:75–76
  33. Shaw FE, Graham DJ, Guess HA, Milstein JB, Johnson JM, Schatz GC, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol. 1988;127:337–352
  34. Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol. 2004;22:749–755
  35. Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain-Barré syndrome after vaccination in United States: data from the Centers of Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Events Reporting System (1990–2005). J Clin Neuromuscular Dis. 2009;11:1–6
  36. Van Doorn PA. What's new in Guillain-Barré syndrome in 2007–2008?. J Peripher Nerv Syst. 2009;14:72–74
  37. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain-Barré syndrome following influenza vaccination. JAMA. 2004;292:2478–2481
  38. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, et al. The Guillain-Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med. 1998;339:1797–1802
  39. Haber P, Seivar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf. 2009;32:309–323
  40. Bourgeais AM, Dore MX, Croue A, Leclech C, Verret JL. Cutaneous polyarteritis nodosa following hepatitis B vaccination. Ann Dermatol Venereol. 2003;130:205–207
  41. De Carvalho JF, Pereira RM, Shoenfeld Y. Systemic polyarteritis nodosa following hepatitis B vaccination. Eur J Intern Med. 2008;19:575–578
  42. De Keyser F, Naeyart JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, et al. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000;18:81–85
  43. Kerleau JM, Lévesque H, Lair G, Lecomte F, Carrara O, Courtois H. Is hepatitis B a new cause of necrotizing vasculitis?. Rev Med Interne. 1997;18:491–492
  44. Le Goff P, Fauquert P, Youinou P, Hoang S. Periarteritis nodosa following vaccination against hepatitis B. Presse Med. 1988;17:1763
  45. Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC. Postvaccine vasculitis: a report of three cases. Rev Med Interne. 2001;22:172–176
  46. Ventura F, Antunes H, Brito C, Pardal F, Pereira T, Vieira AP. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination. Eur J Dermatol. 2009;19:400–401
  47. Allen MB, Cockwell P, Page RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax. 1993;48:580–581
  48. Cockwell P, Allen MB, Page R. Vasculitis related to hepatitis B vaccine. Brit Med J. 1990;301:1281
  49. Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999;26:191–194
  50. Mathieu E, Fain O, Krivitzky A. Cryoglobulinemia after hepatitis B vaccination. N Engl J Med. 1996;335:355
  51. Neau D, Laharie D, Zerbib F, Longy-Boursier M, Le Bras M. Vascularite grave après vaccination contre l'hepatite B: une observation. Rev Méd Interne. 1996;17(Supplement 1):142
  52. Carmeli Y, De-Medina T. Serious hepatitis B adverse reactions: are they immune-mediated. Vaccine. 1993;11:1358–1359
  53. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet. 1970;2:1149–1153
  54. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). 1995;74:238–253
  55. Begier EM, Langford CA, Sneller MC, Wise RP, Ball R. Polyarteritis nodosa reports to the Vaccine Adverse Event Reporting System (VAERS): implications for assessment of suspected vaccine-provoked vasculitis. J Rheumatol. 2004;31:2181–2188
  56. Biron P, Montpetit P, Infante-Rivard C, Léry L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Int Med. 1988;148:2685
  57. Domigo V, Authier FJ, Bachoud-Levi AC, Gherardi RK, Degos JD. Should hepatitis B vaccine be contra-indicated in myasthenia gravis?. Autoimmunity. 1999;29:139–140
  58. Louzir B, Othmani S, Battikh R, Ben Abdelhafidh N, Bahri M, Taalouche L, et al. Myasthenia gravis after hepatitis B vaccination. Therapie. 2003;58:378–379
  59. Fernandez-Funez A, Polo Romero FJ. Juvenile dermatomyositis concomitant with hepatitis B vaccination. Med Clin (Barc). 1998;111:675
  60. Ramirez-Rivera J, Vega-Cruz AM, Jaume-Anselmi F. Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome. Bol Assoc Med PR. 2003;95:13–16
  61. Capasso M, Di Muzio A, Comar M, Robuffo I, Gambi A, Crovella S, et al. The association of chronic hepatitis B and myopathy. Neurology. 2006;67:1467–1469
  62. Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999;38:978–983

PII: S0022-510X(10)00092-4

doi: 10.1016/j.jns.2010.02.016

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 1-4 , 15 May 2010

Article Tools